February 19, 2020

In CABG with Bilateral ITAs, Tailor Target Vessel Choice to Myocardial Mass

Large study takes on a nuanced strategy question for the first time


Survival following coronary artery bypass graft surgery (CABG) using bilateral internal thoracic artery (ITA) grafts is substantially influenced by the proportion of total myocardial mass perfused by the targeted vessels, a new Cleveland Clinic study finds.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Our findings support the use of a bilateral ITA approach that maximizes the myocardium supplied by the ITAs and steers clear of less-important targets,” says Cleveland Clinic cardiothoracic surgeon Faisal Bakaeen, MD, lead author of the large retrospective analysis, which was published in the Journal of the American College of Cardiology (JACC) (2020;75:258-268).

Distinguishing ‘important’ and ‘less important’ targets

Whereas a survival benefit is well established for use of an ITA versus a saphenous vein bypass to the left anterior descending coronary artery (LAD), strong evidence is lacking for use of a second ITA graft rather than a vein graft for non-LAD targets.

So Dr. Bakaeen and colleagues retrospectively reviewed all 6,127 patients who underwent bilateral ITA grafting at Cleveland Clinic from January 1972 to January 2011. Of this group, 2,551 patients received one ITA graft to the LAD and had an assessable preoperative coronary angiogram.

Among these patients, the researchers set out to determine the survival effect of grafting to a dominant LAD — defined as one wrapped around the left ventricular apex — as well as to non-LAD target vessels. They scrutinized the angiograms to categorize non-LAD targets on the basis of their terminal reach toward the apex, with targets having > 75% reach graded as important (n = 1,698) and targets with ≤ 75% reach graded as less important (n = 853).

Mean follow-up duration was 14 ± 8.7 years, and multivariate analysis was used to pinpoint risk factors for mortality over time.


Key findings

Analysis showed that patients in whom less-important additional target vessels were used were more likely to have a dominant LAD than were patients with important target vessels (51% vs. 35%; P < 0.0001). Overall, 179 patients (7.0%) had a second ITA grafted to multiple targets, and 43% of these cases involved multiple important targets.

While unadjusted survival was not influenced by the importance of the second ITA target, multivariate analysis revealed that grafting a second ITA to multiple important non-LAD targets was associated with significantly improved long-term survival relative to using a second ITA to only one important target or to nonimportant targets (P = 0.005). In patients with a nondominant LAD, grafting a second ITA to a less-important vessel was associated with a higher risk of operative mortality relative to grafting to an important vessel (2.4% vs. 0.51%; P = 0.007).

Saphenous vein grafts had no effect on long-term survival among recipients of bilateral ITAs, regardless of target importance.

Takeaways for practice

“In patients who receive bilateral ITA grafts, choosing an anatomically important vessel for the second ITA is associated with lower surgical mortality in patients with a nondominant LAD,” notes Dr. Bakaeen. “Additionally, bypassing multiple important target vessels is associated with improved long-term survival. I would think of it as a dose-response relationship between the mass of cardiac muscle supplied by the ITA and patient survival. The best survival is achieved when all important targets are bypassed with ITAs when possible.”

In their study report, he and his co-authors translate their findings to two takeaway practical recommendations for formulating a bilateral ITA strategy:

  • Use ITAs (or arterial grafts) to revascularize the greatest myocardial mass.
  • When the LAD is nondominant, priority should be given to grafting the second ITA to all important targets that reach toward the heart’s apex.

“Our findings suggest that objective methods for quantifying the share of total myocardium perfused by each potential arterial target may help optimize long-term outcomes of CABG,” Dr. Bakaeen concludes.

An additional perspective

In an accompanying editorial in JACC, cardiac surgeons from Cedars-Sinai Medical Center and the Icahn School of Medicine at Mount Sinai salute the Cleveland Clinic authors for “providing a uniquely granular insight into the importance of target anatomy” in coronary bypass surgery.

They add that the study provides “an honest insight into some of the challenges involved in adopting a multiarterial revascularization strategy across a wider platform.” The long-term rewards of such a strategy, they conclude, are “best realized through an individualized approach to target selection by surgeons with proficiency in multiarterial revascularization.”

Related Articles

x-ray of bone fracture in a forearm
March 1, 2024
TRAVERSE Substudy Links Testosterone Therapy to Increased Fracture Risk in Older Men With Hypogonadism

Surprise findings argue for caution about testosterone use in men at risk for fracture

photo of intubated elderly woman in hospital bed
February 23, 2024
Proteomic Study Characterizes Markers of Frailty in Cardiovascular Disease and Their Links to Outcomes

Findings support emphasis on markers of frailty related to, but not dependent on, age

GettyImages-1252287413 [Converted]
September 8, 2023
Black Residents of Historically Redlined Areas Have Increased Heart Failure Risk

Large database study reveals lingering health consequences of decades-old discrimination

23-HVI-4172009 CQD 650&#215;450-2
August 29, 2023
Updates From CLEAR Outcomes and VALOR-HCM: Expanded Benefits With Bempedoic Acid and Mavacamten

Additional analyses of the two trials presented at 2023 ESC Congress

January 6, 2022
Study Confirms Quality-of-Life Benefits of Myectomy in Obstructive HCM

Prospective SPIRIT-HCM trial demonstrates broad gains over 12-month follow-up

21-HVI-2211308 gender-scales_650x450
August 10, 2021
8 Ways to Increase Women’s Participation in Cardiovascular Trials

An ACC committee issues recommendations to accelerate sluggish progress

December 4, 2020
Carotid Endarterectomy and the High-Risk Patient

Review of our recent experience shows it’s still a safe option

November 30, 2020
AI Looms Large in New Studies of Heart Transplant Rejection and Noncompaction Cardiomyopathy

Machine learning may improve risk prediction and guide therapy